Cargando…

Correction: PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma

Detalles Bibliográficos
Autores principales:	Xia, Tian, Liu, Ming, Zhao, Quan, Ouyang, Jian, Xu, Peipei, Chen, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608793/ https://www.ncbi.nlm.nih.gov/pubmed/34811355 http://dx.doi.org/10.1038/s41419-021-04373-5

Ejemplares similares

PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma
por: Xia, Tian, et al.
Publicado: (2021)

PRMT5 inhibitors on the (myeloma) road
por: Gulla, Annamaria, et al.
Publicado: (2018)

Identification of a Pyroptosis-Related Gene Signature and Effect of Silencing the CHMP4C and CASP4 in Pancreatic Adenocarcinoma
por: Chen, Yajun, et al.
Publicado: (2022)

Testis cell pyroptosis mediated by CASP1 and CASP4: possible sertoli cell-only syndrome pathogenesis
por: Liu, Wantao, et al.
Publicado: (2023)

Correction: Structure of the Arginine Methyltransferase PRMT5-MEP50 Reveals a Mechanism for Substrate Specificity
por: Ho, Meng-Chiao, et al.
Publicado: (2013)

Unsupervised Integration of Multiple Protein Disorder Predictors: The Method and Evaluation on CASP7, CASP8 and CASP9 Data
por: Zhang, Ping, et al.
Publicado: (2011)

Correction: PRMT1 suppresses ATF4-mediated endoplasmic reticulum response in cardiomyocytes
por: Jeong, Myong-Ho, et al.
Publicado: (2020)

Correction to: PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling
por: Yao, Bing, et al.
Publicado: (2021)

Protein Arginine Methyltransferase 5 (PRMT5) has prognostic relevance and is a druggable target in Multiple Myeloma
por: Gullà, Annamaria, et al.
Publicado: (2017)

Correction: Identification and Characterization of New Molecular Partners for the Protein Arginine Methyltransferase 6 (PRMT6)
por: Lo Sardo, Alessandra, et al.
Publicado: (2013)

Correction to: PRMT6 physically associates with nuclear factor Y to regulate photoperiodic flowering in Arabidopsis
por: Zhang, Pingxian, et al.
Publicado: (2021)

Correction to: Isatuximab: A Review of Its Use in Multiple Myeloma
por: Frampton, James E.
Publicado: (2021)

Influence of the naturally occurring human CASP1 variant L265S on subcellular distribution and pyroptosis
por: Rabe, S, et al.
Publicado: (2015)

Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis
por: McCurdy, Arleigh, et al.
Publicado: (2023)

Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach
por: Vlummens, Philip, et al.
Publicado: (2022)

A novel prognostic model based on pyroptosis-related genes for multiple myeloma
por: Zhang, Cuiling, et al.
Publicado: (2023)

Correction for: CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation
por: Lin, Zigen, et al.
Publicado: (2023)

PRMT1 loss sensitizes cells to PRMT5 inhibition
por: Gao, Guozhen, et al.
Publicado: (2019)

Correction to: Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
por: Yu, Bo, et al.
Publicado: (2020)

Correction: Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma
por: Raninga, Prahlad V., et al.
Publicado: (2021)

Author Correction: Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response
por: Szewczyk, Magdalena M., et al.
Publicado: (2020)

Correction: Non-coding RNAs in necroptosis, pyroptosis and ferroptosis in cancer metastasis
por: Liu, Yan, et al.
Publicado: (2021)

TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma
por: Nakayama, Kazuhide, et al.
Publicado: (2018)

Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
por: Chim, C. S., et al.
Publicado: (2019)

Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
por: Girgis, Suzette, et al.
Publicado: (2022)

Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
por: Kurata, Keiji, et al.
Publicado: (2023)

Correction: Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
por: Lopez-Muñoz, N., et al.
Publicado: (2023)

MiRNAs with prognostic significance in multiple myeloma: A systemic review and meta-analysis
por: Xu, Peipei, et al.
Publicado: (2019)

Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making
por: Zhu, Jun, et al.
Publicado: (2023)

Correction to: Pyroptosis: a new paradigm of cell death for fighting against cancer
por: Tan, Yixin, et al.
Publicado: (2021)

Correction to: Pyroptosis: a new paradigm of cell death for fighting against cancer
por: Tan, Yixin, et al.
Publicado: (2021)

Correction: Association between CASP8 –652 6N Del Polymorphism (rs3834129) and Colorectal Cancer Risk: Results from a Multi-Centric Study
Publicado: (2014)

PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression
por: Liu, Ming, et al.
Publicado: (2020)

Correction: HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
por: Jia, Chuiming, et al.
Publicado: (2023)

Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
por: Yellapantula, Venkata, et al.
Publicado: (2020)

Polycomb Target Genes Are Silenced in Multiple Myeloma
por: Kalushkova, Antonia, et al.
Publicado: (2010)

Author Correction: Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway
por: Chen, Yan, et al.
Publicado: (2023)

Author Correction: Accelerated single cell seeding in relapsed multiple myeloma
por: Landau, Heather J., et al.
Publicado: (2021)

Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
por: Ferreira, André C., et al.
Publicado: (2021)

Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation
por: Sainski, Amy M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_accjcrsda0idbrrubokefeumrn